Synchronous carotid stenting and cardiac surgery: An initial single-center experience
Autor: | Oscar, Mendiz, Mendiz, Oscar, Carlos, Fava, Fava, Carlos, León, Valdivieso, Valdivieso, León, Eduardo, Dulbecco, Dulbecco, Eduardo, Héctor, Raffaelli, Raffaelli, Héctor, Gustavo, Lev, Lev, Gustavo, Roberto, Favaloro, Favaloro, Roberto |
---|---|
Rok vydání: | 2006 |
Předmět: |
Male
medicine.medical_specialty Carotid Artery Common medicine.medical_treatment Population Heart Valve Diseases Carotid endarterectomy Severity of Illness Index Blood Vessel Prosthesis Implantation Angioplasty Internal medicine medicine Humans Carotid Stenosis Radiology Nuclear Medicine and imaging Hospital Mortality cardiovascular diseases Myocardial infarction Coronary Artery Bypass education Stroke Aged Aged 80 and over Heart Valve Prosthesis Implantation education.field_of_study business.industry Coronary Stenosis General Medicine Length of Stay Middle Aged medicine.disease Clopidogrel Cardiac surgery Surgery Treatment Outcome Aortic Valve cardiovascular system Cardiology Mitral Valve Female Stents Carotid stenting Cardiology and Cardiovascular Medicine business Follow-Up Studies medicine.drug |
Zdroj: | Catheterization and Cardiovascular Interventions. 68:424-428 |
ISSN: | 1522-726X 1522-1946 |
DOI: | 10.1002/ccd.20883 |
Popis: | Concurrent severe carotid and cardiac disease is a challenging situation where staged surgery is probably the most common strategy, although it is still controversial. We report in-hospital and midterm outcome of 30 patients who received carotid stenting and synchronous cardiac surgery. All received carotid stenting under aspirin and regular unfractioned heparin (UFH) and were immediately transferred to the operating room for coronary and/or cardiac valve surgery. All patients received aspirin and clopidogrel once bleeding was ruled out, after surgery. In-hospital complications were: three surgical related deaths, one TIA, and no patient suffered stroke or myocardial infarction. Hospital stay was 14 ± 11.8 days. Survivors were followed for 18.4 ± 14 months. There were two non-related deaths, but no stroke nor cardiac or carotid reinterventions. In conclusion, this small series showed that synchronous carotid stenting and cardiac surgery was feasible with an acceptable complication rate in a high-surgical-risk population which could not undergo staged procedures. © 2006 Wiley-Liss, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |